Erythrokinetic studies were performed on 10 patients with chronic myelofibrosis and 11 patients with myelodysplasia (MDS). Values for plasma iron turnover, marrow iron turnover, and erythron transferrin uptake were derived using two ferrokinetic models. One entailed analysis of the extended plasma iron clearance over a number of days, the other comprised analysis of the initial plasma iron clearance during the first few hours of the study. We analysed data derived from both models for the same patients to assess the comparability of the results obtained. Ten cases of chronic myelofibrosis and 11 cases of myelodysplasia (MDS) were studied in this way.
The use of ferrokinetic studies to quantify erythropoiesis during haematological investigations has not been widely applied. While traditional measurements are relatively simple to perform, the variables which are derivednamely, plasma iron clearance, plasma iron turnover, and red cell utilisation, provide only limited information on the efficiency of total haemopoietic tissue in the production of mature, viable red cells. ' The introduction of a mathematical model for analysis of plasma iron clearance over 14 days has yielded clinically significant data.2 Erythropoietic activity is reflected by the marrow iron turnover, quantifying total erythropoiesis; red cell iron turnover, quantifying effective erythropoiesis; and ineffective iron turnover, quantifying ineffective erythropoiesis. Application of this methodology has also been limited as it is labour intensive, may require admission to hospital, entails the use of sophisticated computing facilities, and requires specialist interpretation.
An alternative approach, comprising a one day study, and calculation of erythron transferrin uptake as a measure of total erythropoiesis has been advocated. Comparativeferrokinetic study with initial and extended iron clearance models ferrin uptake and plasma iron turnover. The evaluation of erythropoiesis by morphological remaining cases (cases 2, 3, 5, 7, 9 and 10) were analysis alone may prove difficult. Application assigned to cluster B, typified by lower levels of ferrokinetic studies results in both direct and for erythron transferrin uptake and plasma iron objective quantitation, and provides valuable turnover. For the group with MDS, the results information regarding erythropoiesis. allocated one case only (case 14) to cluster A,
The determination of plasma iron clearance, the remainder being assigned to cluster B. For red cell utilisation, and plasma iron turnover the extended plasma iron clearance data, five alone is, at best, uninformative and, at worst, cases of myelofibrosis (cases 1, 3, 4, 6, and 8) misleading. Mathematical analysis of the were assigned to cluster A, characterised by extended plasma iron clearance line2 provides increased values for both marrow iron turnover meaningful data, but the procedure is timeand plasma iron turnover. The remaining cases consuming, labour intensive, and presents (cases 2, 5, 7, 9 and 10) were assigned to cluster problems regarding patient reattendance or B, typified by lower levels for marrow iron admission. Analysis of the initial plasma iron turnover and plasma iron turnover. For the clearance line3 produces information which, group with MDS, one case only (case 14) was although less detailed, may be as informative in assigned to cluster A, the remainder being assessing erythropoiesis. assigned to cluster B. With the exception of Data generated from 1O myelofibrosis and 11 case 3, both ferrokinetic models were in MDS patients were analysed by both methods agreement regarding the allocation of cases to to rationalise the laboratory assessment of cluster type.
erythropoiesis. Some differences were obtained for the plasma iron turnover in the initial and extended clearance studies. This may reflect Discussion the fact that we adhered strictly to the respecMyelofibrosis and MDS are complex tive methodologies, no corrections being made haematological disorders. In both conditions for serum iron fluctuation for the initial The main advantage of the extended plasma iron clearance model2 is its ability to detect levels of effective and ineffective erythropoiesis, although doubts have been expressed about the validity of these interpretations, particularly in patients with haemolytic disorders.'3 14 Nevertheless, our experience has been that a meticulous approach to the methodology produces clinically meaningful results. It is also possible to use the ferrokinetic data from this model to calculate the red cell lifespan. Careful attention must be given, however, to the erythropoietic activity of the patient because the success of this method depends on a steady rate of erythroid activity relative to the circulating red cell mass.
A one-day analysis of the initial plasma iron clearance line does not involve the use of sophisticated curve fitting procedures and can provide erythropoietic information which may not be readily apparent from cell morphology alone.3 Although our work has shown that both methodologies produce comparable data as regards levels of total erythropoiesis, the practical advantages provided by Cazzola's approach would be further enhanced if the proportion of the total erythron transferrin uptake directed to effective erythropoiesis was delineated.3 This may be possible by using the 5'Cr red cell lifespan measurement and the haemoglobin concentration to calculate the iron turnover directed to effective erythropoiesis. This could then be expressed as an "effective erythron transferrin uptake" by allowing for the transferrin saturation, thus enabling calculation of the fraction of the total erythron transferrin uptake directed to effective erythropoiesis (Martin J Pippard, personal communication). Unfortunately, there may still be problems with interpretation because this calculation assumes that the percentage saturation of the total iron binding capacity remained constant throughout the two hour study period. Application of this method could theoretically provide valuable data regarding erythropoietic activity, but a 14 day study period would still be required for calculation of the 5'Cr red cell lifespan. Nevertheless, we consider that the potential for additional information justifies further investigation of this approach.
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